Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized, Double-Blind, Vehicle-Controlled, Efficacy and Safety Clinical Trial of Topically Applied OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With Osteoarthritis of the Knee Following Cessation of Pain Therapy

NCT01768975 is registered in ClinicalTrials.gov with Olatec Therapeutics, Inc. as lead sponsor.

NCT NCT01768975
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01768975 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized, Double-Blind, Vehicle-Controlled, Efficacy and Safety Clinical Trial of Topically Applied OLT1177 Gel in Subjects With Moderate to Severe Pain Associated With Osteoarthritis of the Knee Following Cessation of Pain Therapy
Lead sponsor
Olatec Therapeutics, Inc.
Phase
Phase 2
Overall status
Completed
Start date
January 31, 2013
Completion date
August 31, 2013
Enrollment
79 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

osteoarthritis of the knee